Merck will collaborate with nonprofit research organization IAVI on COVID-19 vaccine. The company will use the same virus technology used in its Ebola vaccine. The vaccine candidate is currently in preclinical development with clinical trials expected to start this year. (CNBC)

Pharmacies are expecting more demand for flu vaccines in the fall. Pharmacies including CVS, Rite Aid, Walgreens and Walmart are working to secure more vaccines. Rite Aid ordered 40% more vaccine doses than usual. (Reuters)

Medicaid will now have plans that limit copays on insulin. The new plans will limit copays to $35 on insulin. The government worked with insurers and insulin makers Eli Lilly, Novo Nordisk and Sanofi to come to the deal. (Associated Press)

Eli Lilly and Junshi Biosciences are planning to begin human trials of COVID-19 antibodies in Q2. In preclinical studies, the antibody showed substantial neutralization activity against the virus. The clinical trials will take place in the U.S. and China. (Reuters)

Frontline workers could receive a coronavirus vaccine by the end of this year, said Novavax CEO. Novavax has launched phase one clinical trials of its coronavirus vaccine candidate and it expects preliminary results in July. (CNBC)